Smoking cessation and the risk of diabetes mellitus and impaired fasting glucose: Three-year outcomes after a quit attempt

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Stein, James H ^a   Asthana, Asha ^a   Smith, Stevens S ^a   Piper, Megan E ^a   Loh, Wei Yin ^a   Fiore, Michael C ^a   Baker, Timothy B ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DYSGLYCEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING; SMOKING CESSATION; WAIST CIRCUMFERENCE; WEIGHT GAIN; BLOOD; DIET RESTRICTION; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84902532294     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098278     Document Type: Article

References (41)

1. CDC (Center for Disease Control) (2004) The Health Consequences of Smoking: A Report of the Surgeon General. U.S. Government Printing Office, Washington, DC.
2. Wannamethee SG, Shaper AG, Perry IJ (2001) Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care 24: 1590-1595.
3. Will JC, Galuska DA, Ford ES, Mokdad A, Calle EE (2001) Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int J Epidemiol 30: 540-546. (Pubitemid 32600247)
4. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J (2007) Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 298: 2654-2664. (Pubitemid 350254957)
5. Nakanishi N, Nakamura K, Matsuo Y, Suzuki K, Tatara K (2000) Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men. Ann Intern Med 133: 183-191. (Pubitemid 30617056)
6. Hur NW, Kim HC, Nam CM, Jee SH, Lee HC, et al. (2007) Smoking cessation and risk of type 2 diabetes mellitus: Korea Medical Insurance Corporation Study. Eur J Cardiovasc Prev Rehabil 14: 244-249. (Pubitemid 46656033)
7. Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P (2012) Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ 345: e4439.
8. Lycett D, Munafo M, Johnstone E, Murphy M, Aveyard P (2011) Associations between weight change over 8 years and baseline body mass index in a cohort of continuing and quitting smokers. Addiction 106: 188-196.
9. O'Hara P, Connett JE, Lee WW, Nides M, Murray R, et al. (1998) Early and late weight gain following smoking cessation in the Lung Health Study. Am J Epidemiol 148: 821-830. (Pubitemid 28484100)
10. Yeh HC, Duncan BB, Schmidt MI, Wang NY, Brancati FL (2010) Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med 152: 10-17.
11. Balkau B, Vierron E, Vernay M, Born C, Arondel D, et al. (2006) The impact of 3-year changes in lifestyle habits on metabolic syndrome parameters: the D.E.S.I.R study. Eur J Cardiovasc Prev Rehabil 13: 334-340. (Pubitemid 44318642)
12. Clair C, Rigotti NA, Porneala B, Fox CS, D'Agostino RB, et al. (2013) Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA 309: 1014-1021.
13. Luo J, Rossouw J, Margolis KL (2013) Smoking cessation, weight change, and coronary heart disease among postmenopausal women with and without diabetes. JAMA 310: 94-96.
14. Oba S, Noda M, Waki K, Nanri A, Kato M, et al. (2012) Smoking cessation increases short-term risk of type 2 diabetes irrespective of weight gain: the Japan Public Health Center-Based Prospective Study. PLoS One 7: e17061.
15. Fishman PA, Thompson EE, Merikle E, Curry SJ (2006) Changes in health care costs before and after smoking cessation. Nicotine Tob Res 8: 393-401. (Pubitemid 43977041)
16. Piper ME, Smith SS, Schlam TR, Fiore MC, Jorenby DE, et al. (2009) A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry 66: 1253-1262.
17. Johnson HM, Gossett LK, Piper ME, Aeschlimann SE, Korcarz CE, et al. (2010) Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol 55: 1988-1995.
18. Gepner AD, Piper ME, Johnson HM, Fiore MC, Baker TB, et al. (2011) Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J 161: 145-151.
19. Hosmer DW, Lemeshow S (2000) Applied Logistic Regression. Second Edition ed. New York: John Wiley & Sons.
20. Clark MM, Decker PA, Offord KP, Patten CA, Vickers KS, et al. (2004) Weight concerns among male smokers. Addict Behav 29: 1637-1641. (Pubitemid 39296531)
21. Jeffery RW, Hennrikus DJ, Lando HA, Murray DM, Liu JW (2000) Reconciling conflicting findings regarding postcessation weight concerns and success in smoking cessation. Health Psychol 19: 242-246.
22. Loh WY (2009) Improving the precision of classification trees. Ann Appl Stat 3: 1710-1737.
23. Daniel M, Cargo MD (2004) Association between smoking, insulin resistance and beta-cell function in a North-western First Nation. Diabet Med 21: 188-193. (Pubitemid 38221820)
24. Ostgren CJ, Lindblad U, Ranstam J, Melander A, Rastam L (2000) Associations between smoking and beta-cell function in a non-hypertensive and non-diabetic population. Skaraborg Hypertension and Diabetes Project. Diabet Med 17: 445-450. (Pubitemid 30471339)
25. Saccone NL, Schwantes-An TH, Wang JC, Grucza RA, Breslau N, et al. (2010) Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans. Genes Brain Behav 9: 741-750.
26. Weiss RB, Baker TB, Cannon DS, von Niederhausern A, Dunn DM, et al. (2008) A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet 4: e1000125.
27. Broderick P, Wang Y, Vijayakrishnan J, Matakidou A, Spitz MR, et al. (2009) Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res 69: 6633-6641.
28. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452: 633-637. (Pubitemid 351483367)
29. Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, et al. (2009) A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 5: e1000421.
30. (2008) State-specific prevalence of obesity among adults - United States, 2007. MMWR Morb Mortal Wkly Rep 57: 765-768.
31. Chelland CS, Moffatt RJ, Stamford BA (2008) Smoking and smoking cessation - the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis 201: 225-235.
32. Siapush M, Singh GK, Tibbits M, Pinard CA, Shaikh RA, et al. (2013) Is it better to be a fat ex-smoker than a thin smoker: findings from the 1997-2004 National Health Interview Survey-National Death Index Linkage Study. Tobacco Control April 10 [Epub ahead of print].
33. Fiore MC, Baker TB (2013) Should clinicians encourage smoking cessation for every patient who smokes? JAMA 309: 1032-1033.
34. Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, et al. (2003) The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26: 3230-3236. (Pubitemid 37466880)
35. Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, et al. (2009) 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374: 1677-1686.
36. McBride PE, Einerson JA, Grant H, Sargent C, Underbakke G, et al. (2008) Putting the Diabetes Prevention Program into practice: a program for weight loss and cardiovascular risk reduction for patients with metabolic syndrome or type 2 diabetes mellitus. J Nutr Health Aging 12: 745S-749S.
37. Yang M, Bhowmik D, Wang X, Abughosh S (2013) Does combination pharmacological intervention for smoking cessation prevent post-cessation weight gain? A systemic review. Addict Behav 38: 1865-1875.
38. Farley AC, Hajek P, Lycett D, Aveyard P (2012) Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev 1: CD006219.
39. Baker TB, Mermelstein R, Collins LM, Piper ME, Jorenby DE, et al. (2011) New methods for tobacco dependence treatment research. Ann Behav Med 41: 192-207.
40. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, et al. (2006) Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 296: 47-55.
41. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, et al. (2006) Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 296: 56-63.